Neurology Associates, PC

Lincoln, Nebraska 68510

0 studies enrolling now · 13 studies all time

What they study most

ALS, Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, Central Neuropathic Pain, Motor Neuron Disease, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Nervous System Diseases, Neurodegenerative Diseases, Neuromuscular Diseases, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) — Completed
• Open Label Extension Study of AMX0035 in Patients With ALS — Completed
• Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
• AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis — Status unconfirmed
• Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• Phase 3 Study of Dexpramipexole in ALS — Completed
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Clinical Trial Nuedexta in Subjects With ALS — Completed